Genomed Spólka Akcyjna (WSE:GEN)

Genomed Spólka Akcyjna Statistics

Total Valuation

WSE:GEN has a market cap or net worth of PLN 36.73 million. The enterprise value is 32.62 million.

Market Cap	36.73M
Enterprise Value	32.62M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:GEN has 1.32 million shares outstanding.

Current Share Class	648,283
Shares Outstanding	1.32M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.76%
Owned by Institutions (%)	n/a
Float	41,650

Valuation Ratios

The trailing PE ratio is 16.70.

PE Ratio	16.70
Forward PE	n/a
PS Ratio	1.46
PB Ratio	3.33
P/TBV Ratio	3.35
P/FCF Ratio	28.24
P/OCF Ratio	15.91
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.63, with an EV/FCF ratio of 25.08.

EV / Earnings	14.83
EV / Sales	1.30
EV / EBITDA	10.63
EV / EBIT	13.96
EV / FCF	25.08

Financial Position

The company has a current ratio of 7.70

Current Ratio	7.70
Quick Ratio	6.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	4,107.31

Financial Efficiency

Return on equity (ROE) is 21.68% and return on invested capital (ROIC) is 14.40%.

Return on Equity (ROE)	21.68%
Return on Assets (ROA)	12.66%
Return on Invested Capital (ROIC)	14.40%
Return on Capital Employed (ROCE)	20.57%
Revenue Per Employee	474,296
Profits Per Employee	41,501
Employee Count	54
Asset Turnover	2.18
Inventory Turnover	4.62

Taxes

In the past 12 months, WSE:GEN has paid 182,563 in taxes.

Income Tax	182,563
Effective Tax Rate	7.66%

Stock Price Statistics

The stock price has decreased by -1.43% in the last 52 weeks. The beta is -0.12, so WSE:GEN's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	-1.43%
50-Day Moving Average	25.70
200-Day Moving Average	26.94
Relative Strength Index (RSI)	77.91
Average Volume (20 Days)	15

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:GEN had revenue of PLN 25.14 million and earned 2.20 million in profits.

Revenue	25.14M
Gross Profit	16.20M
Operating Income	2.34M
Pretax Income	2.38M
Net Income	2.20M
EBITDA	3.07M
EBIT	2.34M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 4.12 million in cash and n/a in debt, giving a net cash position of 4.12 million or 3.12 per share.

Cash & Cash Equivalents	4.12M
Total Debt	n/a
Net Cash	4.12M
Net Cash Per Share	3.12
Equity (Book Value)	11.02M
Book Value Per Share	n/a
Working Capital	7.55M

Cash Flow

In the last 12 months, operating cash flow was 2.31 million and capital expenditures -1.01 million, giving a free cash flow of 1.30 million.

Operating Cash Flow	2.31M
Capital Expenditures	-1.01M
Free Cash Flow	1.30M
FCF Per Share	0.98

Margins

Gross margin is 64.43%, with operating and profit margins of 9.30% and 8.75%.

Gross Margin	64.43%
Operating Margin	9.30%
Pretax Margin	9.48%
Profit Margin	8.75%
EBITDA Margin	12.21%
EBIT Margin	9.30%
FCF Margin	5.17%

Dividends & Yields

WSE:GEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	5.99%
FCF Yield	3.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7